Financial reports
10-K
2023 FY
Annual report
1 Apr 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
27 Apr 23
10-K
2022 FY
Annual report
15 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
10-Q
2022 Q1
Quarterly report
13 May 22
10-K
2021 FY
Annual report
18 Mar 22
Current reports
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
25 Apr 24
8-K
Acorda Therapeutics Announces Delisting from Nasdaq
17 Apr 24
8-K
Acorda Therapeutics and Merz Announce Signing of “Stalking Horse” Asset Purchase Agreement
1 Apr 24
8-K
Amendments to Articles of Incorporation or Bylaws
13 Mar 24
8-K
Termination of a Material Definitive Agreement
11 Jan 24
8-K
Other Events
1 Dec 23
8-K
Acorda Therapeutics Reports Third Quarter 2023 Financial Results
13 Nov 23
8-K
Acorda Therapeutics Reports Second Quarter 2023 Financial Results
8 Aug 23
8-K
Departure of Directors or Certain Officers
27 Jun 23
8-K
Other Events
26 Jun 23
Registration and prospectus
25-NSE
Exchange delisting
25 Apr 24
S-8
Registration of securities for employees
16 Aug 22
424B5
Prospectus supplement for primary offering
13 Jan 21
424B4
Prospectus supplement with pricing info
17 Sep 20
S-3
Shelf registration
11 Sep 20
S-3
Shelf registration
11 Sep 20
424B4
Prospectus supplement with pricing info
6 Jul 20
S-3
Shelf registration
29 Jun 20
424B4
Prospectus supplement with pricing info
24 Jan 20
S-3
Shelf registration
15 Jan 20
Proxies
DEF 14A
Definitive proxy
27 Apr 23
DEFA14A
Additional proxy soliciting materials
27 Apr 23
DEFA14A
Additional proxy soliciting materials
7 Nov 22
DEFA14A
Additional proxy soliciting materials
1 Nov 22
DEFA14A
Additional proxy soliciting materials
31 Oct 22
DEFA14A
Additional proxy soliciting materials
31 Oct 22
DEFA14A
Additional proxy soliciting materials
28 Oct 22
DEFA14A
Additional proxy soliciting materials
27 Oct 22
DEFA14A
Additional proxy soliciting materials
26 Oct 22
DEFA14A
Additional proxy soliciting materials
25 Oct 22
Other
EFFECT
Notice of effectiveness
18 Sep 20
EFFECT
Notice of effectiveness
18 Sep 20
UPLOAD
Letter from SEC
18 Sep 20
CORRESP
Correspondence with SEC
16 Sep 20
CORRESP
Correspondence with SEC
16 Sep 20
UPLOAD
Letter from SEC
16 Sep 20
EFFECT
Notice of effectiveness
7 Jul 20
CORRESP
Correspondence with SEC
1 Jul 20
UPLOAD
Letter from SEC
30 Jun 20
CT ORDER
Confidential treatment order
11 May 20